Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries.
The report details the trend, potential and market size of Bioengineered Protein Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bioengineered Protein Drugsmarket, defines the market attractiveness level of Bioengineered Protein Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bioengineered Protein Drugs industry, describes the types of Bioengineered Protein Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bioengineered Protein Drugs market and the development prospects and opportunities of Bioengineered Protein Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bioengineered Protein Drugs market in Chapter 13.
By Player:
Bayer AG
Johnson & Johnson (Janssen)
Novartis AG
Dr Reddy's Laboratories Ltd
Biocon Ltd,
Dr Reddy's Laboratories Ltd
Eli Lily and Company
Sanofi, Amgen Inc
Bayer AG
Abbott Laboratories
Panacea Biotec
Reliance Life Sciences Pvt Ltd
Merck & Co, Inc
FHoffmann-La Roche Ltd
By Type:
Monoclonal Antibody
Therapeutic Proteins
Blood Factor
Enzyme Therapy
Thrombolytics
Vaccines
By End-User:
Pharma and Biotech Companies
CROs
Research Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bioengineered Protein Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bioengineered Protein Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bioengineered Protein Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bioengineered Protein Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bioengineered Protein Drugs Market Analysis and Outlook to 2022
-
7.1 Global Bioengineered Protein Drugs Consumption (2017-2022)
-
7.2 United States Bioengineered Protein Drugs Consumption (2017-2022)
-
7.3 Europe Bioengineered Protein Drugs Consumption (2017-2022)
-
7.4 China Bioengineered Protein Drugs Consumption (2017-2022)
-
7.5 Japan Bioengineered Protein Drugs Consumption (2017-2022)
-
7.6 India Bioengineered Protein Drugs Consumption (2017-2022)
-
7.7 South Korea Bioengineered Protein Drugs Consumption (2017-2022)
8 Region and Country-wise Bioengineered Protein Drugs Market Analysis and Outlook to 2028
-
8.1 Global Bioengineered Protein Drugs Consumption Forecast (2022-2028)
-
8.2 United States Bioengineered Protein Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Bioengineered Protein Drugs Consumption Forecast (2022-2028)
-
8.4 China Bioengineered Protein Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Bioengineered Protein Drugs Consumption Forecast (2022-2028)
-
8.6 India Bioengineered Protein Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Bioengineered Protein Drugs Consumption Forecast (2022-2028)
9 Global Bioengineered Protein Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Bioengineered Protein Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapeutic Proteins Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Blood Factor Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Enzyme Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Thrombolytics Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Bioengineered Protein Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharma and Biotech Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global CROs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Global Bioengineered Protein Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Bioengineered Protein Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Therapeutic Proteins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Blood Factor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Enzyme Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Thrombolytics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bioengineered Protein Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pharma and Biotech Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global CROs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Bioengineered Protein Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bioengineered Protein Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bioengineered Protein Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bioengineered Protein Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bioengineered Protein Drugs Market Competitive Analysis
-
14.1 Bayer AG
-
14.1.1 Bayer AG Company Details
-
14.1.2 Bayer AG Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer AG Bioengineered Protein Drugs Product and Service
-
14.2 Johnson & Johnson (Janssen)
-
14.2.1 Johnson & Johnson (Janssen) Company Details
-
14.2.2 Johnson & Johnson (Janssen) Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson (Janssen) Bioengineered Protein Drugs Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Bioengineered Protein Drugs Product and Service
-
14.4 Dr Reddy's Laboratories Ltd
-
14.4.1 Dr Reddy's Laboratories Ltd Company Details
-
14.4.2 Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Product and Service
-
14.5 Biocon Ltd,
-
14.5.1 Biocon Ltd, Company Details
-
14.5.2 Biocon Ltd, Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biocon Ltd, Bioengineered Protein Drugs Product and Service
-
14.6 Dr Reddy's Laboratories Ltd
-
14.6.1 Dr Reddy's Laboratories Ltd Company Details
-
14.6.2 Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Product and Service
-
14.7 Eli Lily and Company
-
14.7.1 Eli Lily and Company Company Details
-
14.7.2 Eli Lily and Company Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lily and Company Bioengineered Protein Drugs Product and Service
-
14.8 Sanofi, Amgen Inc
-
14.8.1 Sanofi, Amgen Inc Company Details
-
14.8.2 Sanofi, Amgen Inc Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi, Amgen Inc Bioengineered Protein Drugs Product and Service
-
14.9 Bayer AG
-
14.9.1 Bayer AG Company Details
-
14.9.2 Bayer AG Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer AG Bioengineered Protein Drugs Product and Service
-
14.10 Abbott Laboratories
-
14.10.1 Abbott Laboratories Company Details
-
14.10.2 Abbott Laboratories Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Laboratories Bioengineered Protein Drugs Product and Service
-
14.11 Panacea Biotec
-
14.11.1 Panacea Biotec Company Details
-
14.11.2 Panacea Biotec Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Panacea Biotec Bioengineered Protein Drugs Product and Service
-
14.12 Reliance Life Sciences Pvt Ltd
-
14.12.1 Reliance Life Sciences Pvt Ltd Company Details
-
14.12.2 Reliance Life Sciences Pvt Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Reliance Life Sciences Pvt Ltd Bioengineered Protein Drugs Product and Service
-
14.13 Merck & Co, Inc
-
14.13.1 Merck & Co, Inc Company Details
-
14.13.2 Merck & Co, Inc Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Merck & Co, Inc Bioengineered Protein Drugs Product and Service
-
14.14 FHoffmann-La Roche Ltd
-
14.14.1 FHoffmann-La Roche Ltd Company Details
-
14.14.2 FHoffmann-La Roche Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 FHoffmann-La Roche Ltd Bioengineered Protein Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bioengineered Protein Drugs
-
Figure Bioengineered Protein Drugs Picture
-
Table Global Bioengineered Protein Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bioengineered Protein Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bioengineered Protein Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bioengineered Protein Drugs Consumption by Country (2017-2022)
-
Figure United States Bioengineered Protein Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Bioengineered Protein Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Bioengineered Protein Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Bioengineered Protein Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Bioengineered Protein Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bioengineered Protein Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Bioengineered Protein Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Bioengineered Protein Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bioengineered Protein Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bioengineered Protein Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bioengineered Protein Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bioengineered Protein Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bioengineered Protein Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Factor Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Thrombolytics Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Pharma and Biotech Companies Consumption and Growth Rate (2017-2022)
-
Figure Global CROs Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thrombolytics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharma and Biotech Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CROs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bioengineered Protein Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bioengineered Protein Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Bioengineered Protein Drugs Product and Service
-
Table Johnson & Johnson (Janssen) (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson (Janssen) Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson (Janssen) Bioengineered Protein Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Bioengineered Protein Drugs Product and Service
-
Table Dr Reddy's Laboratories Ltd (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Product and Service
-
Table Biocon Ltd, (Foundation Year, Company Profile and etc.)
-
Table Biocon Ltd, Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Ltd, Bioengineered Protein Drugs Product and Service
-
Table Dr Reddy's Laboratories Ltd (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Ltd Bioengineered Protein Drugs Product and Service
-
Table Eli Lily and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lily and Company Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lily and Company Bioengineered Protein Drugs Product and Service
-
Table Sanofi, Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Sanofi, Amgen Inc Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi, Amgen Inc Bioengineered Protein Drugs Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Bioengineered Protein Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Bioengineered Protein Drugs Product and Service
-
Table Panacea Biotec (Foundation Year, Company Profile and etc.)
-
Table Panacea Biotec Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Panacea Biotec Bioengineered Protein Drugs Product and Service
-
Table Reliance Life Sciences Pvt Ltd (Foundation Year, Company Profile and etc.)
-
Table Reliance Life Sciences Pvt Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reliance Life Sciences Pvt Ltd Bioengineered Protein Drugs Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Bioengineered Protein Drugs Product and Service
-
Table FHoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table FHoffmann-La Roche Ltd Bioengineered Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table FHoffmann-La Roche Ltd Bioengineered Protein Drugs Product and Service
-
